SMAD2 and Bloom syndrome: In the present study (Figures 2– 4), we have confirmed that α -MG treatment can dramatically activate AMPK and inhibited NOX4 expression as well as TGF-β1/Smad2/3 signaling pathway in lung tissues compared with the BLM alone group.